208 related articles for article (PubMed ID: 28757653)
1. Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the Breast.
Mathew A; Rajagopal PS; Villgran V; Sandhu GS; Jankowitz RC; Jacob M; Rosenzweig M; Oesterreich S; Brufsky A
Geburtshilfe Frauenheilkd; 2017 Jun; 77(6):660-666. PubMed ID: 28757653
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.
Shah C; Wilkinson JB; Shaitelman S; Grills I; Wallace M; Mitchell C; Vicini F
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e547-51. PubMed ID: 21640491
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
[TBL] [Abstract][Full Text] [Related]
4. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N
Breast J; 2015; 21(5):533-7. PubMed ID: 26190560
[TBL] [Abstract][Full Text] [Related]
5. The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients.
Korhonen T; Kuukasjärvi T; Huhtala H; Alarmo EL; Holli K; Kallioniemi A; Pylkkänen L
Breast; 2013 Dec; 22(6):1119-24. PubMed ID: 23863867
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
[TBL] [Abstract][Full Text] [Related]
7. Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast.
Fernández B; Paish EC; Green AR; Lee AH; Macmillan RD; Ellis IO; Rakha EA
J Clin Pathol; 2011 Nov; 64(11):995-1000. PubMed ID: 21712309
[TBL] [Abstract][Full Text] [Related]
8. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
Sinha PS; Bendall S; Bates T
Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of the Clinicopathological Features, Metastasis Sites and Survival Outcomes of Invasive Lobular, Invasive Ductal and Mixed Invasive Ductal and Lobular Breast Carcinoma.
Duraker N; Hot S; Akan A; Nayır PÖ
Eur J Breast Health; 2020 Jan; 16(1):22-31. PubMed ID: 31912010
[TBL] [Abstract][Full Text] [Related]
10. Lobular Breast Cancer and Abdominal Metastases: A Retrospective Review and Impact on Survival.
Winn JS; Baker MG; Fanous IS; Slack-Davis JK; Atkins KA; Dillon PM
Oncology; 2016; 91(3):135-42. PubMed ID: 27355204
[TBL] [Abstract][Full Text] [Related]
11. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C
Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022
[TBL] [Abstract][Full Text] [Related]
12. Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy.
Wong H; Lau S; Cheung P; Wong TT; Parker A; Yau T; Epstein RJ
BMC Cancer; 2014 Nov; 14():826. PubMed ID: 25385074
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
[TBL] [Abstract][Full Text] [Related]
14. Metastatic pattern of invasive lobular carcinoma of the breast-Emphasis on gastric metastases.
El-Hage A; Ruel C; Afif W; Wissanji H; Hogue JC; Desbiens C; Leblanc G; Poirier É
J Surg Oncol; 2016 Oct; 114(5):543-547. PubMed ID: 27406466
[TBL] [Abstract][Full Text] [Related]
15. Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences.
Kwast AB; Groothuis-Oudshoorn KC; Grandjean I; Ho VK; Voogd AC; Menke-Pluymers MB; van der Sangen MJ; Tjan-Heijnen VC; Kiemeney LA; Siesling S
Breast Cancer Res Treat; 2012 Aug; 135(1):271-80. PubMed ID: 22810087
[TBL] [Abstract][Full Text] [Related]
16. Infiltrating lobular carcinoma of the breast presenting as gastrointestinal obstruction: a mini review.
Carcoforo P; Raiji MT; Langan RC; Lanzara S; Portinari M; Maestroni U; Palini GM; Zanzi MV; Bonazza S; Pedriali M; Feo CV; Stojadinovic A; Avital I
J Cancer; 2012; 3():328-32. PubMed ID: 22866167
[TBL] [Abstract][Full Text] [Related]
17. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
[TBL] [Abstract][Full Text] [Related]
18. Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers.
Romanska HM; Potemski P; Krakowska M; Mieszkowska M; Chaudhri S; Kordek R; Kubiak R; Speirs V; Hanby AM; Sadej R; Berditchevski F
Br J Cancer; 2015 Nov; 113(9):1350-7. PubMed ID: 26418423
[TBL] [Abstract][Full Text] [Related]
19. Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin.
Braunstein LZ; Brock JE; Chen YH; Truong L; Russo AL; Arvold ND; Harris JR
Breast Cancer Res Treat; 2015 Jan; 149(2):555-64. PubMed ID: 25604797
[TBL] [Abstract][Full Text] [Related]
20. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
Moran MS; Yang Q; Haffty BG
Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
